UnitedHealth Group announced that CEO Andrew Witty is stepping down due to 'personal reasons,' and former CEO Stephen Hemsley will replace him.

UnitedHealth has been hammered in a number of ways: increased costs, political pressure over its size, and scrutiny by the Federal Trade Commission and Department of Justice. Cong

The moves follows Brian Thompson's murder, sharp public criticism, and a major blow to the insurer's stock price.

UnitedHealth has faced several headwinds in the recent past, ranging from a cyberattack, which had greater than initially realized impacts, to the tragic killing of its CEO, which caused the company to suffer harsh public backlash over the company's and industry practices.

UnitedHealth CEO Andrew Witty is stepping down for personal reasons and the nation’s largest health insurer suspended its full-year financial outlook due to higher-than-expected medical costs. Chairman Stephen Hemsley will become CEO, effective immediately, the Minnesota company said.

UnitedHealth Group Chief Executive Officer Andrew Witty stepped down, effective immediately, "for personal reasons", the company said Tuesday. “Leading the people of UnitedHealth Group has been a tremendous honor as they work every day to improve the health system, and they will continue to inspire me,” Witty said in a statement shared by UHG.

UnitedHealth Group (UNH) stock opened more than 2.5% higher on Wednesday following the previous session's staggering loss of 17.8%. The fallout from the largest private health insurer in the US suspending its guidance as it deals with higher than expected medical costs has sent shivers down the spines of institutional shareholders.

UnitedHealth Group Incorporated stock drops after a rare earnings miss and CEO resignation. Click for the impact and potential buying opportunity in UNH at $335.

Por MICHELLE CHAPMANEl director general de UnitedHealth, Andrew Witty, dejará su cargo por razones personales y la aseguradora de salud más grande del país suspendió su

UnitedHealth Group shares rebounded modestly Wednesday following yesterday's crash, with analysts from UBS, Oppenheimer, and Morgan Stanley leaving their ratings unchanged after the health insurer pulled its outlook and announced its CEO had stepped down.